62 related articles for article (PubMed ID: 1425313)
1. [Ondansetron in carcinoid syndrome].
Buhl C; Fibbe C; Frenzel H
Dtsch Med Wochenschr; 1992 Nov; 117(47):1821. PubMed ID: 1425313
[No Abstract] [Full Text] [Related]
2. Treatment of diarrhea in carcinoid syndrome with ondansetron, tropisetron, and clonidine.
Schwörer H; Münke H; Stöckmann F; Ramadori G
Am J Gastroenterol; 1995 Apr; 90(4):645-8. PubMed ID: 7717328
[TBL] [Abstract][Full Text] [Related]
3. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
Kiesewetter B; Duan H; Lamm W; Haug A; Riss P; Selberherr A; Scheuba C; Raderer M
Oncologist; 2019 Feb; 24(2):255-258. PubMed ID: 30171068
[TBL] [Abstract][Full Text] [Related]
4. Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome.
Wymenga AN; de Vries EG; Leijsma MK; Kema IP; Kleibeuker JH
Eur J Cancer; 1998 Jul; 34(8):1293-4. PubMed ID: 9849494
[TBL] [Abstract][Full Text] [Related]
5. Ondansetron in carcinoid syndrome.
Platt AJ; Heddle RM; Rake MO; Smedley H
Lancet; 1992 Jun; 339(8806):1416. PubMed ID: 1375972
[No Abstract] [Full Text] [Related]
6. [The carcinoid syndrome].
Marcussen H
Ugeskr Laeger; 1970 Jun; 132(25):1183-7. PubMed ID: 5449339
[No Abstract] [Full Text] [Related]
7. Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Rubin J; O'Connell MJ
Cancer Treat Rep; 1986 Dec; 70(12):1459-60. PubMed ID: 3791259
[No Abstract] [Full Text] [Related]
8. Efficacy of orally disintegrating ondansetron in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomised, double-blind placebo controlled study.
Grover VK; Mathew PJ; Hegde H
Anaesthesia; 2009 Jun; 64(6):595-600. PubMed ID: 19453311
[TBL] [Abstract][Full Text] [Related]
9. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case].
Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC
Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698
[TBL] [Abstract][Full Text] [Related]
10. Effect of melphalan in the malignant carcinoid syndrome.
Lotito CA; Mengel CE
Arch Intern Med; 1969 Jul; 124(1):36-8. PubMed ID: 5791484
[No Abstract] [Full Text] [Related]
11. Malignant carcinoid syndrome. Failure of anti-oestrogenic therapy.
Ramcharan K; Pooransingh C; Harnarayan C; Shah-Parsad M; McFarlane H
West Indian Med J; 1990 Mar; 39(1):47-51. PubMed ID: 2333698
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
13. Freeze dried ondansetron: first observations with the fast dissolving oral antiemetic Zofran Zydis for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients.
Lehoczky O; Udvary J; Pulay T
Neoplasma; 2002; 49(2):126-8. PubMed ID: 12088106
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of a patient with carcinoid syndrome with SMS-201-995 (octreotide) for 32 months].
Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; García Camba L; Durán Pérez-Navarro A
An Med Interna; 1993 Jun; 10(6):309. PubMed ID: 8334213
[No Abstract] [Full Text] [Related]
15. [Medical treatment of the carcinoid syndrome].
Roncoroni M; Facciuto EM
Prensa Med Argent; 1966 Jul; 53(27):1493-6. PubMed ID: 5990483
[No Abstract] [Full Text] [Related]
16. [Parachlorophenylalanine and ultrastructure in the carcinoid syndrome].
Rapado A; Oliva H; Traba ML; Díaz Recasens J; Ríuz F; Pérez-Corral F; Farré J; De la Barreda P
Rev Clin Esp; 1974 Jan; 132(1):11-20. PubMed ID: 4276185
[No Abstract] [Full Text] [Related]
17. [Carcinoid tumor--diagnostic and therapeutic problems].
Batowski S; Bielewicz A
Pol Tyg Lek; 1994 Jun 6-13; 49(23-24):536-7. PubMed ID: 7675710
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
Altman AR; Tschen JA; Rice L
Arch Dermatol; 1989 Mar; 125(3):394-6. PubMed ID: 2923448
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid and carcinoid syndrome].
Sukhareva GV; Khomeriki SG
Eksp Klin Gastroenterol; 2008; (3):110-9. PubMed ID: 19145891
[No Abstract] [Full Text] [Related]
20. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
van Houten AA; Nortier JW; Vendrik CP
Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
